CO2023010155A2 - Derivados de pirazolamida - Google Patents
Derivados de pirazolamidaInfo
- Publication number
- CO2023010155A2 CO2023010155A2 CONC2023/0010155A CO2023010155A CO2023010155A2 CO 2023010155 A2 CO2023010155 A2 CO 2023010155A2 CO 2023010155 A CO2023010155 A CO 2023010155A CO 2023010155 A2 CO2023010155 A2 CO 2023010155A2
- Authority
- CO
- Colombia
- Prior art keywords
- pyrazolamide
- derivatives
- formula
- present
- compounds
- Prior art date
Links
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical class NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La presente invención proporciona compuestos de fórmula I o II: en donde X1, R1 y R2 son como se describe en la presente, así como también sales de estos farmacéuticamente aceptables. Además, la presente invención se refiere a la fabricación de compuestos de fórmula I, composiciones farmacéuticas que los comprenden y su uso como medicamentos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21154295 | 2021-01-29 | ||
| PCT/EP2022/051823 WO2022162034A1 (en) | 2021-01-29 | 2022-01-27 | Pyrazoleamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2023010155A2 true CO2023010155A2 (es) | 2023-09-08 |
Family
ID=74418268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2023/0010155A CO2023010155A2 (es) | 2021-01-29 | 2023-07-28 | Derivados de pirazolamida |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20230382911A1 (es) |
| EP (1) | EP4284797A1 (es) |
| JP (1) | JP2024504788A (es) |
| KR (1) | KR20230141787A (es) |
| CN (1) | CN116867782A (es) |
| AR (1) | AR124720A1 (es) |
| AU (1) | AU2022212487A1 (es) |
| CA (1) | CA3209599A1 (es) |
| CL (1) | CL2023002052A1 (es) |
| CO (1) | CO2023010155A2 (es) |
| CR (1) | CR20230331A (es) |
| IL (1) | IL304189A (es) |
| MX (1) | MX2023008562A (es) |
| PE (1) | PE20231387A1 (es) |
| TW (1) | TW202246259A (es) |
| WO (1) | WO2022162034A1 (es) |
| ZA (1) | ZA202306694B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024151112A1 (ko) * | 2023-01-11 | 2024-07-18 | 주식회사 티움바이오 | 사이클린 의존성 키나아제 9 저해제로서의 피라졸로피리미딘 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014207213A1 (en) * | 2013-06-28 | 2014-12-31 | Medizinische Universität Innsbruck | Novel inhibitors of protein kinase c epsilon signaling |
| KR20170137165A (ko) | 2015-04-10 | 2017-12-12 | 베이진 엘티디 | 인돌아민 및/또는 트립토판 2,3-디옥시게나아제로서 신규한 5 또는 8-치환된 이미다조[1,5-a]피리딘 |
| CN106146493A (zh) | 2015-04-21 | 2016-11-23 | 中国科学院上海药物研究所 | 吡唑并[3,4-b]吡啶类和吲唑类化合物的制备方法和用途 |
-
2022
- 2022-01-26 TW TW111103282A patent/TW202246259A/zh unknown
- 2022-01-27 KR KR1020237026475A patent/KR20230141787A/ko unknown
- 2022-01-27 AU AU2022212487A patent/AU2022212487A1/en active Pending
- 2022-01-27 CN CN202280012462.8A patent/CN116867782A/zh active Pending
- 2022-01-27 MX MX2023008562A patent/MX2023008562A/es unknown
- 2022-01-27 WO PCT/EP2022/051823 patent/WO2022162034A1/en active Application Filing
- 2022-01-27 EP EP22702930.3A patent/EP4284797A1/en active Pending
- 2022-01-27 CA CA3209599A patent/CA3209599A1/en active Pending
- 2022-01-27 PE PE2023002122A patent/PE20231387A1/es unknown
- 2022-01-27 CR CR20230331A patent/CR20230331A/es unknown
- 2022-01-27 JP JP2023545924A patent/JP2024504788A/ja active Pending
- 2022-01-28 AR ARP220100176A patent/AR124720A1/es unknown
-
2023
- 2023-06-29 ZA ZA2023/06694A patent/ZA202306694B/en unknown
- 2023-07-02 IL IL304189A patent/IL304189A/en unknown
- 2023-07-14 CL CL2023002052A patent/CL2023002052A1/es unknown
- 2023-07-28 US US18/361,526 patent/US20230382911A1/en active Pending
- 2023-07-28 CO CONC2023/0010155A patent/CO2023010155A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL304189A (en) | 2023-09-01 |
| WO2022162034A1 (en) | 2022-08-04 |
| ZA202306694B (en) | 2024-03-27 |
| CL2023002052A1 (es) | 2023-12-22 |
| AU2022212487A1 (en) | 2023-07-13 |
| CR20230331A (es) | 2023-09-01 |
| AR124720A1 (es) | 2023-04-26 |
| AU2022212487A9 (en) | 2024-09-26 |
| EP4284797A1 (en) | 2023-12-06 |
| PE20231387A1 (es) | 2023-09-12 |
| CA3209599A1 (en) | 2022-08-04 |
| US20230382911A1 (en) | 2023-11-30 |
| TW202246259A (zh) | 2022-12-01 |
| MX2023008562A (es) | 2023-08-08 |
| CN116867782A (zh) | 2023-10-10 |
| KR20230141787A (ko) | 2023-10-10 |
| JP2024504788A (ja) | 2024-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2022003646A1 (es) | Derivados de amidopirimidona | |
| UY32025A (es) | Derivados sustituídos de la 6-cloro-2-hidroxi-3-(3,4-dioxo-ciclobut-1-enil-amino)-n-metoxi-n-metil-bencen-sulfonamida, solvatos, hidratos o sales farmacéuticamente aceptables de los mismos, proceso de preparación, composiciones y aplicaciones. | |
| BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
| UY31069A1 (es) | Nuevos derivados de imidazoquinola, composiciones conteniendolos, proceso de preparacion y aplicaciones | |
| UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| CU20220005A7 (es) | Inhibidores tricíclicos de kars dependientes de akr1c3 | |
| ECSP23077322A (es) | Derivados de fósforo como nuevos inhibidores de sos1 | |
| UY30938A1 (es) | Derivados de nicotinamida, sales y solvatos farmacéuticamente aceptables, composiciones y aplicaciones. | |
| UY30856A1 (es) | Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk | |
| CL2020001817A1 (es) | Moduladores del receptor c5a | |
| MX2020003993A (es) | Derivados de bencimidazol y sus usos. | |
| UY30363A1 (es) | Derivados sustituidos de la n-(3-oxo-2,3-dihidro-1h-isoindol-4-il)-1-naftamida, procesos de preparacion, composiciones farmacéuticas y aplicaciones | |
| HN2003000162A (es) | Derivados de isoindolona, proceso de preparacion y compuestos intermedios de este proceso, su uso como medicamentos, y composiciones farmaceuticas que los contienen. | |
| CO2023010212A2 (es) | Derivados novedosos de pirimidin-2-il sulfonamida | |
| UY32055A (es) | Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones. | |
| UY39588A (es) | Pirazolotiazol carboxamidas y usos de estas como inhibidores de pdgfr | |
| CL2022002975A1 (es) | Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus métodos de uso | |
| PA8589801A1 (es) | Aminoalcoxiindoles | |
| CO2023010155A2 (es) | Derivados de pirazolamida | |
| DOP2021000103A (es) | Pirazoles como moduladores de hemoglobina | |
| CO2023000858A2 (es) | Inhibidores de atr y usos de estos | |
| CL2022003677A1 (es) | Derivados de sulfona | |
| UY30699A1 (es) | Derivados sustituidos de 4-fenilamino-quinolina-3-carboxamidas, sales farmacéuticamente aceptables, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
| CL2023002322A1 (es) | Derivados de hidroxiheterocicloalquil-carbamoilo | |
| CL2023000970A1 (es) | Espiro derivados de alfa-d-galactopiranosidos |